Time to disease progression in children with relapsed or refractory neuroblastoma treated with ABT-751: a report from the Children's Oncology Group (ANBL0621).
Document Type
Journal Article
Publication Date
6-1-2014
Journal
Pediatric Blood and Cancer
Volume
61
Issue
6
Inclusive Pages
990–996
DOI
10.1002/pbc.24900
APA Citation
Fox, E., Mosse', Y., Meany, H. M., Gurney, J., Khanna, G., Jackson, H., Gordon, G., Shusterman, S., Park, J., Cohn, S., Adamson, P., London, W., Maris, J., & Balis, F. (2014). Time to disease progression in children with relapsed or refractory neuroblastoma treated with ABT-751: a report from the Children's Oncology Group (ANBL0621).. Pediatric Blood and Cancer, 61 (6). http://dx.doi.org/10.1002/pbc.24900
Peer Reviewed
1